卒中后认知障碍(PSCI)相关前瞻性分子生物标志物  

Prospective Molecular Biomarkers Related to Post Stroke Cognitive Impairment

作　　者：辛亮 饶静 魏亚囡 张禄露 徐瑞芬[2] 

机构地区：[1]西安医学院,陕西 西安 [2]陕西省人民医院,陕西 西安

出　　处：《临床医学进展》2022年第11期10759-10765,共7页Advances in Clinical Medicine

摘　　要：卒中后认知障碍(PSCI)是卒中后主要的并发症之一,是血管性认知障碍(VCI)的一个亚型。它的诊断通常要在卒中后3至6个月进行认知评估来最终确定。评估参与卒中后认知障碍发病的潜在因素是预防缺血性卒中患者认知缺陷进展的关键步骤。本综述着重总结有关卒中后认知障碍潜在分子生物标志物的研究。Post stroke cognitive impairment is one of the main complications after stroke and a subtype of vascular cognitive impairment. Its diagnosis is usually finalized by cognitive assessment 3~6 months after stroke. Assessing the potential factors involved in the onset of post-stroke cognitive impairment is a key step to prevent the progression of cognitive impairment in patients with ischemic stroke. This review focuses on summarizing the research on potential molecular biomarkers of post-stroke cognitive impairment.

关 键 词：卒中后认知障碍 缺血性卒中 分子生物标志物 

分 类 号：R74[医药卫生—神经病学与精神病学]